The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes

E-ISSN： 1875-5550|10|1|56-74

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.10, Iss.1, 2009-02, pp. : 56-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Phosphorylase as a Molecular Target for Type 2 Diabetes Therapy

Current Protein and Peptide Science, Vol. 3, Iss. 6, 2002-12 ,pp. : 561-586

Bentham Science Publishers

Access to resources Recommend Favorite

Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system

By Cravatt B.F. Lichtman A.H.

Current Opinion in Chemical Biology, Vol. 7, Iss. 4, 2003-08 ,pp. : 469-475

Elsevier

Access to resources Recommend Favorite

Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes

Current Enzyme Inhibition, Vol. 7, Iss. 4, 2011-12 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Liraglutide for type 2 diabetes mellitus

By Kela Ram Khunti Kamlesh Davies Melanie J

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Orally administered tryptophan and experimental type 2 diabetes

By Tormo M.A. de Tejada A. Morales I. Paredes S. Sánchez S. Barriga C. Hernández R.

Molecular and Cellular Biochemistry, Vol. 261, Iss. 1, 2004-06 ,pp. : 57-61

Springer Publishing Company

Access to resources Recommend Favorite